What is the ACMG/AMP five-tier classification?

It is a consensus framework that sorts sequence variants into five categories, pathogenic, likely pathogenic, uncertain significance, likely benign, and benign, by systematically weighting different types of evidence.

Why do reporting standards matter for molecular tests?

Because the same finding can be acted on differently depending on how it is described, standardized reports ensure the result, its interpretation, and its limitations are communicated consistently and reproducibly.

Reporting Standards and Interpretation Guidelines

Reporting standards and interpretation guidelines govern how a molecular result is turned into a clear, consistent, and clinically usable report. They specify how findings such as detected variants are classified, what evidence supports each classification, and what elements a laboratory report must contain so that clinicians can understand the result, its limitations, and its meaning.

Definition

Reporting standards are the agreed conventions for the content, structure, and clarity of a laboratory report; interpretation guidelines are the evidence-based frameworks that translate raw molecular findings into standardized clinical categories such as pathogenic, likely pathogenic, or variant of uncertain significance.

Scope

The entry covers structured molecular reporting and the frameworks used to interpret and classify findings, most prominently the ACMG/AMP sequence-variant classification system, along with the principles for transparent reporting of diagnostic-accuracy evidence. It is a methodological topic and does not provide clinical interpretation of any individual result.

Core questions

What information must a molecular pathology report contain?
How are sequence variants classified into standardized categories?
What evidence types support a variant classification?
How should the limitations and intended use of a test be communicated?

Key concepts

Structured reporting
ACMG/AMP variant classification (five-tier)
Variant of uncertain significance (VUS)
Evidence weighting and classification criteria
Statement of methods, limitations, and intended use
Reproducibility and standardization of reports
Transparent diagnostic-accuracy reporting (STARD)

Mechanisms

Interpretation guidelines provide explicit criteria for assigning findings to standardized categories. The ACMG/AMP framework, for example, weights multiple evidence types (population frequency, computational predictions, functional data, segregation, and others) to classify sequence variants into five tiers from benign to pathogenic, with an explicit uncertain category (Richards et al., 2015). Reporting standards then require that the report state the method, the result, its interpretation, and its limitations, building on the validated performance of the assay and its pipeline (Jennings et al., 2009; Roy et al., 2018). For the evidence underlying diagnostic claims, the STARD checklist promotes complete and transparent reporting of accuracy studies (Bossuyt et al., 2015).

Clinical relevance

Clear, standardized reports and consistent variant interpretation reduce the chance that a molecular result is misread or misapplied in care. This entry describes the conventions that make reports interpretable and is not itself clinical advice about any specific finding.

Evidence & guidelines

Interpretation and reporting in molecular pathology are shaped by professional consensus, notably the ACMG/AMP variant-interpretation guidelines (Richards et al., 2015) and laboratory validation and reporting standards (Jennings et al., 2009; Roy et al., 2018), with STARD providing the standard for reporting diagnostic-accuracy evidence (Bossuyt et al., 2015).

History

Early molecular reports varied widely in format and in how variants were classified. Joint efforts by the ACMG and AMP produced a shared five-tier classification framework in 2015, and parallel reporting initiatives such as STARD standardized how diagnostic evidence is communicated, moving the field toward reproducible, comparable reports (Richards et al., 2015; Bossuyt et al., 2015).

Debates

How should variants of uncertain significance be handled and reported?: The uncertain category is common and clinically difficult; debate continues over how to communicate it, how to reclassify variants as evidence accrues, and how to avoid over- or under-interpretation.

Seminal works

richards-2015
bossuyt-2015

Frequently asked questions

What is the ACMG/AMP five-tier classification?: It is a consensus framework that sorts sequence variants into five categories, pathogenic, likely pathogenic, uncertain significance, likely benign, and benign, by systematically weighting different types of evidence.
Why do reporting standards matter for molecular tests?: Because the same finding can be acted on differently depending on how it is described, standardized reports ensure the result, its interpretation, and its limitations are communicated consistently and reproducibly.